Anebulo Pharmaceuticals Statistics
Total Valuation
ANEB has a market cap or net worth of $51.77 million. The enterprise value is $36.77 million.
| Market Cap | 51.77M |
| Enterprise Value | 36.77M |
Important Dates
The last earnings date was Friday, February 14, 2025, after market close.
| Earnings Date | Feb 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ANEB has 41.08 million shares outstanding. The number of shares has increased by 2.48% in one year.
| Current Share Class | 41.08M |
| Shares Outstanding | 41.08M |
| Shares Change (YoY) | +2.48% |
| Shares Change (QoQ) | +5.72% |
| Owned by Insiders (%) | 40.54% |
| Owned by Institutions (%) | 3.75% |
| Float | 3.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.46 |
| P/TBV Ratio | 3.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.52
| Current Ratio | 17.52 |
| Quick Ratio | 17.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -33.52 |
Financial Efficiency
Return on equity (ROE) is -71.49% and return on invested capital (ROIC) is -46.65%.
| Return on Equity (ROE) | -71.49% |
| Return on Assets (ROA) | -42.87% |
| Return on Invested Capital (ROIC) | -46.65% |
| Return on Capital Employed (ROCE) | -53.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.56M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.58% in the last 52 weeks. The beta is -1.16, so ANEB's price volatility has been lower than the market average.
| Beta (5Y) | -1.16 |
| 52-Week Price Change | -57.58% |
| 50-Day Moving Average | 1.50 |
| 200-Day Moving Average | 1.91 |
| Relative Strength Index (RSI) | 37.49 |
| Average Volume (20 Days) | 12,614 |
Short Selling Information
The latest short interest is 65,509, so 0.16% of the outstanding shares have been sold short.
| Short Interest | 65,509 |
| Short Previous Month | 87,197 |
| Short % of Shares Out | 0.16% |
| Short % of Float | 1.93% |
| Short Ratio (days to cover) | 1.94 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.00M |
| Pretax Income | -9.35M |
| Net Income | -7.67M |
| EBITDA | n/a |
| EBIT | -8.00M |
| Earnings Per Share (EPS) | -$0.29 |
Balance Sheet
| Cash & Cash Equivalents | 15.00M |
| Total Debt | n/a |
| Net Cash | 15.00M |
| Net Cash Per Share | $0.37 |
| Equity (Book Value) | 14.96M |
| Book Value Per Share | 0.36 |
| Working Capital | 14.52M |
Cash Flow
| Operating Cash Flow | -6.65M |
| Capital Expenditures | n/a |
| Free Cash Flow | -6.65M |
| FCF Per Share | -$0.16 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ANEB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.48% |
| Shareholder Yield | -2.48% |
| Earnings Yield | -14.81% |
| FCF Yield | -12.84% |
Analyst Forecast
The average price target for ANEB is $8.00, which is 534.92% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.00 |
| Price Target Difference | 534.92% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |